Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma

…, WW Busse, A Woodcock, R Forth… - European …, 2014 - Eur Respiratory Soc
The inhaled corticosteroid fluticasone furoate (FF) and the long-acting β 2 agonist vilanterol (VI)
are in development as a combined once-daily therapy for asthma and chronic …

Fluticasone furoate demonstrates efficacy in patients with asthma symptomatic on medium doses of inhaled corticosteroid therapy: an 8-week, randomised, placebo …

…, ER Bleecker, ED Bateman, J Lötvall, R Forth… - Thorax, 2012 - thorax.bmj.com
Background Fluticasone furoate (FF) is a novel inhaled corticosteroid with 24 h activity. FF is
being developed as a once-daily treatment in combination with the long-acting β 2 agonist …

[HTML][HTML] Dose effect of once-daily fluticasone furoate in persistent asthma: a randomized trial

…, ER Bleecker, J Lötvall, A Woodcock, R Forth… - Respiratory …, 2012 - Elsevier
BACKGROUND: This randomized, double-blind, multicenter study was designed to evaluate
the efficacy of inhaled once-daily fluticasone furoate (FF) administered in the evening in …

Fluticasone furoate–vilanterol 100-25 mcg compared with fluticasone furoate 100 mcg in asthma: a randomized trial

…, A Woodcock, WW Busse, EM Kerwin, R Forth… - The Journal of Allergy …, 2014 - Elsevier
Background The inhaled corticosteroid fluticasone furoate (FF) in combination with the long-acting
β 2 -agonist vilanterol (VI) is under development for the treatment of asthma and …

Fluticasone furoate (FF)/vilanterol (100/25 mcg or 200/25 mcg) or FF (100 mcg) in persistent asthma

…, ED Bateman, A Woodcock, WT Toler, R Forth… - Journal of …, 2015 - Taylor & Francis
Objectives: Fluticasone furoate (FF; inhaled corticosteroid) combined with vilanterol (VI; long-acting
beta 2 agonist) is a once-daily therapy for asthma and chronic obstructive pulmonary …

[HTML][HTML] Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial

…, WW Busse, J Lötvall, NG Snowise, R Forth… - Respiratory …, 2011 - Springer
Background Fluticasone furoate (FF) is a novel long-acting inhaled corticosteroid (ICS). This
double-blind, placebo-controlled randomized study evaluated the efficacy and safety of FF …

[HTML][HTML] Efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma: a 24-week placebo and active-controlled randomised trial

…, A Woodcock, EM Kerwin, S Stone, R Forth… - Respiratory …, 2014 - Elsevier
Inhaled corticosteroids (ICSs) improve asthma disease control; once-daily ICS administration
may have advantages for patients. Our objective was to assess the efficacy and safety of …

A decision-logic framework for investigating subsidence problems potentially attributable to gypsum karstification

J Lamont-Black, PL Younger, RA Forth, AH Cooper… - Engineering …, 2002 - Elsevier
Karst regions, especially gypsum ones, are prone to subsidence; this can cause severe
problems in urban areas. However, this subsidence may have causes other than active …

[HTML][HTML] Insights from the AUSTRI study on reliever use before and after asthma exacerbations

…, D Stempel, B Aggarwal, I Boucot, R Forth… - The Journal of …, 2022 - jaci-inpractice.org
In clinical practice, attention to high or rising reliever use may help prevent exacerbations, by
prompting patients to implement their action plan and reminding them to take their regular …

Once‐daily fluticasone furoate 50 mcg in mild‐to‐moderate asthma: a 24‐week placebo‐controlled randomized trial

…, J Lötvall, A Woodcock, H Medley, R Forth… - Allergy, 2014 - Wiley Online Library
Background Inhaled glucocorticosteroids ( ICS ) are the mainstay of treatment in asthma.
Fluticasone furoate ( FF ) is a novel, once‐daily ICS asthma therapy. This study investigated the …